Skip to main content

MoneyWorks4Me

Aarti Drugs informs about loss of share certificate

28 Oct 2021 Evaluate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), Aarti Drugs has informed that the Company has issued Duplicate share certificates in lieu of original share certificates.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1872.30
Dr. Reddys Labs. 1396.00
Cipla 1420.00
Lupin 1968.95
Zydus Lifesciences 1195.00
View more..